---
$id: https://graph.org.ai/products/commodity/51111663
$type: Product
source: UNSPSC
code: "51111663"
title: "Valopicitabine"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Valopicitabine

**UNSPSC Code**: 51111663
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a pyrimidine antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I2T0B5G94M. European Medicines Agency schedules Valopicitabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB35614. Valopicitabine generally arises in the molecular formula C15H24N4O6. The term VALOPICITABINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 20, no. 1, 2006, list 55.) VALOPICITABINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule valopicitabine under HS 29349990 and SITC 51579. As of Q4 2014, VALOPICITABINE remains the US FDA Preferred Term for this commodity. Valopicitabine bears US NLM identifiers UMLS ID C1664150 and NCI Concept Code C66649. SMILES: O1C(N2CCC(NC2=O)N)C(O)(C(OC(=O)C(N)C(C)C)C1CO)C.

